Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 4

TABLE OF CONTENTS Volume 19, Issue 4 (April 2012) In this issue Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement 90 page eBook --- download now for free! Published in January 2012 Key Advances in Medicine summarizes the key clinical studies published in 2011 and highlights the trends to watch for in 2012. The perfect resource for busy medical students, physicians, and clinical researchers who want to catch up with the medical literature from 2011. Don't miss out!   Original Articles Top Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer T T Sahin, H Kasuya, N Nomura, T Shikano, K Yamamura, T Gewen, A Kanzaki, T Fujii, T Sugae, T Imai, S Nomoto, S Takeda, H Sugimoto, T Kikumori, Y Kodera, Y Nishiyama and A Nakao Cancer Gene Ther 2012 19: 229-237; advance online publication, December 23, 2011; 10.1038/cgt.2011.80 Abstract | Full Text Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity K B Stephenson, N G Barra, E Davies, A A Ashkar and B D Lichty Cancer Gene Ther 2012 19: 238-246; advance online publication, December 9, 2011; 10.1038/cgt.2011.81 Abstract | Full Text A novel conditionally replicating adenoviral vector with dual expression of IL-24 and arresten inserted in E1 and the region between E4 and fiber for improved melanoma therapy L Chai, S Liu, Q Mao, D Wang, X Li, X Zheng and H Xia Cancer Gene Ther 2012 19: 247-254; advance online publication, December 23, 2011; 10.1038/cgt.2011.84 Abstract | Full Text Hypoxia imaging predicts success of hypoxia-induced cytosine deaminase/5-fluorocytosine gene therapy in a murine lung tumor model B-F Lee, C-H Lee, N-T Chiu, C-C Hsia, L-H Shen and A-L Shiau Cancer Gene Ther 2012 19: 255-262; advance online publication, January 27, 2012; 10.1038/cgt.2011.87 Abstract | Full Text Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy S Kim, H Youn, M G Song, J H Kang, H K Chung, D S Lee and J-K Chung Cancer Gene Ther 2012 19: 263-270; advance online publication, February 3, 2012; 10.1038/cgt.2011.88 Abstract | Full Text Adenovirus-mediated Aurora A shRNA driven by stathmin promoter suppressed tumor growth and enhanced paclitaxel chemotherapy sensitivity in human breast carcinoma cells M Long, G Yin, L Liu, F Lin, X Wang, J Ren, J Wei, K Dong and H Zhang Cancer Gene Ther 2012 19: 271-281; advance online publication, January 27, 2012; 10.1038/cgt.2011.89 Abstract | Full Text Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells Y Gao, P Whitaker-Dowling, J A Griffin and I Bergman Cancer Gene Ther 2012 19: 282-291; advance online publication, January 13, 2012; 10.1038/cgt.2011.90 Abstract | Full Text Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes A Kanzaki, H Kasuya, K Yamamura, T T Sahin, N Nomura, T Shikano, T Shirota, G Tan, S Fukuda, M Misawa, Y Nishikawa, S Yamada, T Fujii, H Sugimoto, S Nomoto, S Takeda, Y Kodera and A Nakao Cancer Gene Ther 2012 19: 292-298; advance online publication, January 27, 2012; 10.1038/cgt.2011.91 Abstract | Full Text Short Communication Top Germ cell DNA-repair systems—possible tools in cancer research? F Helle Cancer Gene Ther 2012 19: 299-302; advance online publication, February 10, 2012; 10.1038/cgt.2012.1 Abstract | Full Text Advertisement Leukemia SPOTLIGHTS - focusing on topical research in the field of leukemia and allied diseases. Have you read the latest collections? miRNA and Hematopoiesis Guest Editor: Dr. Monique L. den Boer Signaling pathways regulating HSC Guest Editor: Prof. F Staal Explore the full series at www.nature.com/leu/spotlights   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.